Definitive Healthcare (NASDAQ:DH) reported second-quarter fiscal 2026 revenue and profitability that met or exceeded its guidance ranges, while management pointed to improving retention trends and continued investments in artificial intelligence products as key components of its plan to return to gr
Fluent (NASDAQ:FLNT) reported second-quarter 2026 revenue growth as its Commerce Media Solutions business expanded sharply and became a larger share of the company’s overall mix. Management said the quarter marked a milestone in the company’s strategic shift toward commerce media, while maintaining
Fastly (NASDAQ:FSLY) executives outlined the company’s efforts to broaden its security portfolio, improve go-to-market execution and capitalize on demand related to artificial intelligence at KeyBanc Capital Markets’ Technology Leadership Forum.
Rich Wong, Fastly’s chief financial officer, said the
Beachbody (NASDAQ:BODI) reported second-quarter 2026 revenue of $49.6 million, exceeding the midpoint of its guidance range, while extending its streak of positive operating income, net income and adjusted EBITDA as the company continues shifting toward a nutrition-led, multi-channel model.
Executi
CeriBell (NASDAQ:CBLL) reported second-quarter 2026 revenue growth of 33% as increased utilization at existing hospital accounts and continued customer additions supported results. The company also raised its full-year revenue outlook and outlined plans to commercially launch its delirium-monitoring
AlTi Global (NASDAQ:ALTI) reported second-quarter 2026 revenue growth and higher assets under management, while an unexpected wind-down of an external Asian credit strategy led to a nearly $19 million unrealized investment loss and a wider net loss from continuing operations.
Assets under managemen
BridgeBio Pharma (NASDAQ:BBIO) reported continued growth for its ATTR cardiomyopathy treatment Attruby in the second quarter of 2026, while advancing three late-stage programs into regulatory review and expanding commercial preparations for potential launches over the next year.
Chief Executive Off
Alamar Biosciences (NASDAQ:ALMR) reported second-quarter 2026 revenue of $29.4 million, up 82% from $16.2 million a year earlier, as growth in consumables, instrument placements and service revenue supported the company’s first earnings call since completing its April initial public offering.
Chief
Your vehicle’s braking system depends on several components working together, and the brake lines play one of the most important roles. When you press the
Pangaea Logistics (NASDAQ:PANL) fell short of the market’s revenue expectations in Q2 CY2026, but sales rose 19.4% year on year to $187.1 million. Its non-GA...
Motion control and electronic systems manufacturer Helios Technologies (NYSE:HLIO) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sa...
JFrog (NASDAQ:FROG) Chief Financial Officer Ed Grabscheid said artificial intelligence-driven software development is increasing the volume of binaries moving through software supply chains, creating demand for the company’s software management and security platform.
Speaking at KeyBanc’s Park City
